13F-HR filed by Casdin Capital, LLC
Casdin Capital, LLC filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 41 holding rows worth $1,213,998,640.
- Accession
- 0000919574-23-003310
- Filer
- CIK 1534261
- Filed
- 2023-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A holdings report, 41 entries on the cover page, a total value of $1,213,998,640 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,213,998,640 with VALUE read as dollars as filed, 13F file number 028-17113. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BIOLIFE SOLUTIONS INC COM NEW | 09062W204 | Stock | 7,571,535 | $164,680,886 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 1,160,000 | $159,882,800 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 5,698,574 | $93,855,514 | dollars as filed | |
| EQRX INC | 26886C107 | COM | 39,527,669 | $76,683,678 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 275,000 | $63,951,250 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 270,000 | $54,086,400 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 1,275,000 | $47,519,250 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 1,675,000 | $44,555,000 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 1,810,000 | $39,204,600 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 565,000 | $38,312,650 | dollars as filed | |
| SEMA4 HOLDINGS CORP | 81663L101 | COM | 102,151,785 | $37,285,402 | dollars as filed | |
| SOMALOGIC INC | 83444K105 | COM | 12,604,275 | $32,140,901 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 2,120,571 | $30,578,634 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 670,000 | $30,143,300 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 1,300,000 | $29,952,000 | dollars as filed | |
| MAXCYTE INC | 57777K106 | COM | 4,925,000 | $24,378,750 | dollars as filed | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 2,023,913 | $20,643,913 | dollars as filed | |
| ABCELLERA BIOLOGICS INC COM | 00288U106 | Stock | 2,520,000 | $19,000,800 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 510,000 | $18,961,800 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 1,070,000 | $18,393,300 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 570,000 | $17,453,400 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 6,078,860 | $17,324,751 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 677,017 | $16,106,234 | dollars as filed | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 150,000 | $16,098,000 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 850,000 | $13,047,500 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 2,050,000 | $11,685,000 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 3,206,380 | $11,126,139 | dollars as filed | |
| TWIST BIOSCIENCE CORP | 90184D100 | COM | 700,000 | $10,556,000 | dollars as filed | |
| ABSCI CORPORATION | 00091E109 | COM | 5,393,260 | $9,438,205 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 734,350 | $9,032,505 | dollars as filed | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 310,000 | $8,881,500 | dollars as filed | |
| OPTIMIZERX CORP | 68401U204 | COM NEW | 500,000 | $7,315,000 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 77,500 | $5,600,925 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 510,882 | $3,979,771 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 1,000,000 | $3,950,000 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 25,000 | $3,445,750 | dollars as filed | call |
| SINGULAR GENOMICS SYSTEMS IN | 82933R100 | COM | 1,345,722 | $1,628,324 | dollars as filed | |
| INVITAE CORP | 46185L103 | COM | 1,038,388 | $1,401,824 | dollars as filed | |
| EXSCIENTIA PLC | 30223G102 | ADS | 213,900 | $1,133,670 | dollars as filed | |
| LIANBIO ADR | 53000N108 | COM | 206,415 | $402,509 | dollars as filed | |
| KRONOS BIO INC | 50107A104 | COM | 123,839 | $180,805 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-23-003310 | this filing | 2023-05-15 | acceptance time not in the bulk data set |